Skip to main content
. 2020 Jul 31;13(5):405–418. doi: 10.1007/s12195-020-00641-0

Figure 4.

Figure 4

Enhanced VEGF-A binding affinity of engineered aflibercept variants. Bio-layer interferometry-based measurements of the interaction kinetics of soluble Fc-fused aflibercept and Fc-fused aflibercept variants (C5, D4, and F3) with immobilized VEGF-A. All soluble proteins were used at a concentration of 100 nM. Response signals were normalized to their respective maximum values.